Skip to Content


In the US, Pindolol (pindolol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat High Blood Pressure.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

Treatment of coronary heart disease

Glaucoma treatment

Antiarrhythmic agent

β-adrenoceptor antagonist (beta blocker), non-cardioselective

Chemical Name

2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-metyletyl)amino]-

Foreign Names

  • Pindololum (Latin)
  • Pindolol (German)
  • Pindolol (French)
  • Pindolol (Spanish)

Generic Names

  • Pindolol (OS: BAN, USAN, JAN, DCF)
  • Pindololo (OS: DCIT)
  • LB-46 (IS)
  • Pindolol (PH: BP 2016, JP XVI, Ph. Eur. 8, USP 38)
  • Pindololum (PH: Ph. Eur. 8)

Brand Names

  • Apo-Pindol
    Apotex, Canada
  • Apo-Pindolol
    Apotex, New Zealand
  • Blocklin-L
    Takata Pharmaceutical, Japan
  • Carvisken
    Alfresa Pharma, Japan
  • durapindol
    Mylan dura, Germany
  • Hexapindol
    Sandoz, Denmark
  • Let Lit
    Kotobuki Seiyaku, Japan
  • Pindolol
    Towa Yakuhin, Taiwan
  • Pindolol CF
    Centrafarm, Netherlands
  • Pindolol Isei
    Koa Isei, Japan
  • Pindolol Mylan
    Mylan, Sweden
  • Pindolol Nichi-iko
    Nichi-Iko Pharmaceutical, Japan
  • Pindolol PCH
    Pharmachemie, Netherlands
  • Pindolol Towa
    Towa Yakuhin, Japan
  • Pinloc
    Orion Pharma, Finland
  • Pithiorol
    Tsuruhara Seiyaku, Taiwan
  • PMS-Pindolol
    Pharmascience, Canada
  • Pyndale
    Crisdy-Na, Philippines
  • Teva-Pindolol
    Teva Canada, Canada
  • Viringal
    Koa Isei, Japan
  • Viskaldix (Pindolol and Clopamide)
    Amdipharm Mercury Company, United Kingdom; Egis, Hungary; Novartis, Brazil; Novartis, Chile; Novartis, France; Novartis, Greece; Novartis, Lebanon; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland
  • Viskazide (Pindolol and Hydrochlorothiazide)
    Novartis Pharmaceuticals, Canada
  • Viskeen
    Novartis, Netherlands
  • Viskeen retard
    Novartis, Netherlands
  • Visken
    Amdipharm Mercury Company, United Kingdom; CSP, France; Egis, Hungary; Egis, Lithuania; Novartis, Belgium; Novartis, Brazil; Novartis, Denmark; Novartis, Finland; Novartis, Greece; Novartis, India; Novartis, Iceland; Novartis, Lebanon; Novartis, Poland; Novartis, Turkey; Novartis, United States; Novartis Healthcare, Philippines; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Teofarma, Italy
  • Viskén
    Novartis, Sweden
  • Visken Quinze
    CSP, France


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.